The topics for discussion include:
- Patent legislation, both from the standpoint of a critical analysis of pending bills and whether other legislation may better reach the results sought;
- Section 101 patent eligibility after Bilski, Prometheus, and Myriad; the law of obviousness post KSR;
- De novo review of claim construction rulings;
- The implications of the Medtronic case now before the Supreme Court on patent licensing in the wake of Medimmune;
- The impact of the Federal Circuit’s decision in Fresenius v. Baxter on patent validity challenges; and
- The ITC’s domestic industry requirement; and proposed reform of appellate jurisdiction in patent cases.
Related Insights
March 13, 2026
Innovative Technology Insights
Increased Flexibility for Graphical User Interface Design Patent Applicants
On March 12, 2026, the U.S. Patent and Trademark Office ("USPTO") released new guidance that updates prior USPTO practice guidelines for the examination of design patent applications for computer-generated interfaces, commonly known as graphical user interfaces ("GUIs") and icons. In response to the evolution of computer technology, the USPTO highlighted additional design patent subject matter and eliminated historical drawing requirements to increase flexibility for applicants in the GUI space.
March 13, 2026
Health Care Law Today
Iran-Linked Cyberattack: What U.S. Companies Need to Know Now
Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the…
March 13, 2026
Innovative Technology Insights
Iran-Linked Cyberattack: What U.S. Companies Need to Know Now
Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the…